First reported by Twitter / X
AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
By
Sheila K. Singh
Source
Nature CommunicationsDual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cellsnature.comNature, Published online: 01 July 2026; doi:10.1038/s41586-026-10641-1 Integrated multi-omic profiling of glioblastoma reveals GPNMB as a shared antigen in tumour cells and the surrounding microenvironment, and GPNMB-targeted chimeric antigen receptor T cells demonstrate therapeutic activity in vitro and in animal models.
You might also wanna read

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·9d ago

Antibody-ligand motif optimization enables multitarget switchable CAR-T therapy against solid tumors
This article presents a research study on optimizing a multitarget switchable CAR-T (sCAR-T) strategy to overcome antigenic heterogeneity an
cell.com·7d ago
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial
doi.org·2d ago
China approves world's first CAR-T cell therapy for solid tumors: CARsgen's satri-cel for advanced gastric cancer
CARsgen Therapeutics has received approval from China's NMPA for satricabtagene autoleucel (satri-cel; CT041), the world's first CAR-T cell
insideprecisionmedicine.com·9d ago
Proteomic and phosphoproteomic profiling reveals melanoma cell responses to T cell attack
This study profiles the early proteomic and phosphoproteomic responses of patient-derived melanoma cells when co-cultured with matched autol
cell.com·8d ago

Study finds cancer-associated somatic mutations in brain immune cells linked to Alzheimer's neuroinflammation
This study investigates the link between Alzheimer's disease (AD) and somatic mutations in brain immune cells. Deep sequencing of 311 brain
cell.com·11d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.